Published in J Cardiovasc Pharmacol on September 01, 1998
Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)alpha agonist and unaffected by an ER beta antagonist. J Endocrinol (2008) 0.88
Postischemic infusion of 17-beta-estradiol protects myocardial function and viability. J Surg Res (2007) 0.85
The Role of Alpha-2 Adrenergic Receptors in Anti-ulcer Activity. Eurasian J Med (2012) 0.75
Prostaglandin: release from the rat phrenic nerve--diaphragm preparation. Science (1965) 2.08
Efflux of prostaglandin from adrenal glands stimulated with acetylcholine. Nature (1966) 2.07
Accurate assessment of right ventricular function in acute respiratory failure. Crit Care Med (1993) 1.99
Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg (2000) 1.94
Spontaneous and evoked release of prostaglandins from cerebral cortex of anesthetized cats. Am J Physiol (1966) 1.93
Release of prostaglandin from rat epididymal fat pad on nervous and hormonal stimulation. J Biol Chem (1968) 1.93
Thin-layer chromatography of 1-dimethylaminonaphthalene-5-sulphonyl derivatives of amino acids present in superfusates of cat cerebral cortex. Biochem J (1967) 1.90
Biological significance of the prostaglandins. Recent Prog Horm Res (1970) 1.81
The vascular protective effects of estrogen. FASEB J (1996) 1.71
Human alveolar macrophages: effects of endotoxin in vitro. Infect Immun (1980) 1.55
Spontaneous and evoked release of prostaglandins from frog spinal cord. Am J Physiol (1966) 1.43
Two cardiac arrests after needle punctures in a patient with mitral valve prolapse: psychogenic? Anesth Analg (1989) 1.39
Vascular activity of polycations and basic amino acids: L-arginine does not specifically elicit endothelium-dependent relaxation. Biochem Biophys Res Commun (1989) 1.31
Sex and age differences in human platelet aggregation. Nature (1975) 1.29
The effect of prostaglandins E1 and E2 on the human erythrocyte as monitored by spin labels. Biochem Biophys Res Commun (1974) 1.27
Vascular responses to arachidonic acid in the perfused canine lung. Circ Res (1976) 1.27
Stochastic hybrid modeling of DNA replication across a complete genome. Proc Natl Acad Sci U S A (2008) 1.24
Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol (1977) 1.23
Endothelium dependent vascular relaxation by arginine containing polypeptides. Biochem Biophys Res Commun (1986) 1.23
Prostaglandin stimulation of rat corticosteroidogenesis. Science (1969) 1.22
Prostaglandin inhibition of gastric secretion. J Physiol (1968) 1.19
Inhibition of intestinal tone and prostaglandin synthesis by 5,8,11,14 tetraynoic acid. Br J Pharmacol (1972) 1.16
Cardiovascular responses to PGI2 (prostacyclin) in the dog. Circ Res (1978) 1.12
Effect of prostaglandin synthesis on renal function and renin in the dog. Nature (1976) 1.12
Prostaglandins in reproductive physiology. Am J Obstet Gynecol (1970) 1.10
Relationship of TXB2 and 6-keto PGF1 alpha to the hemodynamic changes during baboon endotoxic shock. Adv Prostaglandin Thromboxane Res (1980) 1.03
Effects of arachidonic acid on systemic arterial pressure, myocardial contractility and platelets in the dog. Proc Soc Exp Biol Med (1974) 1.03
Role of rostaglandins in reproduction. Physiol Rev (1975) 1.01
Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br J Pharmacol (1993) 0.98
Inhibition of intestinal tone, motility and prostaglandin biosynthesis by 5,8,11,14-eicosatetraynoic acid (TYA). Prostaglandins (1974) 0.98
Lidocaine or indomethacin improves survival in baboon endotoxin shock. J Surg Res (1978) 0.98
Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides (1993) 0.98
Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc (1987) 0.97
Prostaglandin stimulation of in vitro progesterone synthesis. J Clin Endocrinol Metab (1970) 0.96
Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg (1994) 0.96
A comparison of the effects of ACTH, cyclic AMP, Dibutyryl cyclic AMP, and PGE2 on corticosteroidogenesis in vitro. Endocrinology (1972) 0.96
Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol (1993) 0.93
Induced hyperthermia in sedated humans and the concept of critical thermal maximum. Am J Physiol (1978) 0.93
Prostaglandins and the hemodynamic course of endotoxin shock. J Surg Res (1976) 0.92
Release of immunoreactive-neuropeptide by rat platelets. Biochem Biophys Res Commun (1988) 0.92
In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium. Br J Pharmacol (1992) 0.92
Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1 alpha in endometriosis. Am J Obstet Gynecol (1981) 0.91
Biological aspects of prostaglandins. Arch Intern Med (1974) 0.91
Urine i-TXB2 in renal allograft rejection. Lancet (1981) 0.91
Thermographic evidence of reduced sympathetic tone with transcutaneous nerve stimulation. Anesthesiology (1979) 0.91
Thromboxane, prostacyclin, and hemodynamic events in primate endotoxin shock. Adv Shock Res (1981) 0.91
Biological activity of synthetic prostaglandins. Nature (1969) 0.91
Renal actions of prostacyclin. Nature (1978) 0.91
Effect of cyclooxygenase inhibition on the pulmonary vasodilator response to furosemide. J Pharmacol Exp Ther (1988) 0.91
The role of prostaglandins in endotoxemia: comparisons in response in the nonpregnant, maternal, and fetal models. I. Prostaglandins and the pulmonary effect of experimental endotoxemia. Am J Obstet Gynecol (1980) 0.90
Cardiovascular and pulmonary effects of thromboxane B2 in the dog. Circ Res (1979) 0.90
L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol (1996) 0.90
Prostaglandin uptake and metabolism by the perfused rat liver. Br J Pharmacol (1970) 0.90
Resting energy expenditure in controls and cancer patients with localized and diffuse disease. Ann Surg (1984) 0.90
Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction. J Pharmacol Exp Ther (1978) 0.89
NG-monomethyl L-arginine is a non-specific inhibitor of vascular relaxation. Eur J Pharmacol (1989) 0.89
Prostaglandins in shock: to give or to block? Adv Shock Res (1980) 0.89
E. coli endotoxin shock in the dog; treatment with lidocaine or indomethacin. Br J Pharmacol (1978) 0.89
Leukotrienes C4 and D4 induce prostaglandin and thromboxane release from rat peritoneal macrophages. Br J Pharmacol (1981) 0.89
Gonadal hormones and pathogenesis of occlusive arterial thrombosis. Am J Physiol (1978) 0.89
Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581. J Pharmacol Exp Ther (1982) 0.89
Vasodilatory properties of mono-L-arginine-containing compounds. Biochem Biophys Res Commun (1988) 0.89
Superoxide production in the isolated rabbit aorta and the effect of alloxan, indomethacin and nitrovasodilators. J Pharmacol Exp Ther (1991) 0.88
Cellular mechanisms of prostaglandin action. Annu Rev Physiol (1979) 0.88
The antithrombotic nature of vascular prosthetic pseudointima. Surgery (1982) 0.88
Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J Pharmacol Exp Ther (1996) 0.88
The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Circ Shock (1980) 0.87
Role of the endothelium and arginine peptides on the vaso-motor response of porcine internal mammary artery. Life Sci (1989) 0.87
Effects of ganglionic and beta-adrenergic blockade on cardiovascular responses to the bisenoic prostaglandins and their precursor arachidonic acid. Proc Soc Exp Biol Med (1975) 0.87
Effect of testosterone, sex and age on experimentally induced arterial thrombosis. Nature (1976) 0.86
Androgen-mediated sensitivity in platelet aggregation. Am J Physiol (1977) 0.86
Mechanism of cyclosporin potentiation of vasoconstriction of the isolated rat mesenteric arterial bed: role of extracellular calcium. J Pharmacol Exp Ther (1990) 0.86
Cardiovascular and platelet responses in the dog to the monoenoic prostaglandin precursor dihomo-gamma-linolenic acid. Proc Soc Exp Biol Med (1975) 0.86
Peptidyl arginine deiminase and endothelium dependent relaxation. Eur J Pharmacol (1988) 0.86
Ibuprofen modifies the inflammatory response of the murine lung to Pseudomonas aeruginosa. Eur J Respir Dis (1985) 0.86
Antagonism of the pulmonary vasoconstrictor response to prostaglandin F2alpha by N-dimethylamino substitution of prostaglandin F2alpha. J Pharmacol Exp Ther (1978) 0.86
Prostaglandin E2: effects on aggregation, shape change and cyclic AMP of rat platelets. Prostaglandins (1972) 0.86
Prostaglandins: localization in subcellular particles of rat cerebral cortex. Science (1967) 0.85
Role of the vascular endothelium in the contractile response to prostacyclin in the isolated rat aorta. J Pharmacol Exp Ther (1986) 0.85
Estradiol potentiates the vasopressor response of the isolated perfused rat lung to the thromboxane mimic U-46619. J Pharmacol Exp Ther (1992) 0.85
17 beta-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation (1996) 0.84
Biologic importance of arachidonic acid. Arch Intern Med (1981) 0.84
Androgen-mediated sex differences of cardiovascular responses in rats. Am J Physiol (1978) 0.84
Hemodynamic and plasma catecholamine responses to hyperthermic cancer therapy in humans. Am J Physiol (1979) 0.84
Separation, identification, and estimation of prostaglandins. Methods Biochem Anal (1969) 0.84
Coronary artery ultrastructural changes in cardiac transplant atherosclerosis in the rabbit. Transplantation (1991) 0.84
Vascular reactivity in endotoxin shock: effect of lidocaine or indomethacin pretreatment. Adv Shock Res (1982) 0.84
Interaction of non-arginine compounds with the endothelium-derived relaxing factor inhibitor, NG-monomethyl L-arginine. J Pharmacol Exp Ther (1992) 0.84
Effect of cyclosporine A treatment on vascular reactivity of the rat thoracic aorta. Transplant Proc (1988) 0.83
Systemic vascular effects of cyclosporin A treatment in normotensive rats. J Pharmacol Exp Ther (1991) 0.83
Regulation of the arachidonic acid cascade. Biol Reprod (1977) 0.83
Vasoconstrictor response to arachidonic acid in the isolated hind limb of the dog. Br J Pharmacol (1977) 0.83
Matching the rate of concurrent tone bursts and light flashes as a function of flash surround luminance. Percept Psychophys (1981) 0.83
Effects of PGD2 on canine renal function. Nature (1977) 0.83